β¨ Health Notices
NEW ZEALAND GAZETTE, No. 6
17 JANUARY 2008
Health
Crown Entities Act 2004
Reappointment of the Health and Disability Commissioner
Pursuant to section 28(1)(b) of the Crown Entities Act 2004,
His Excellency the Governor-General of New Zealand has reappointed
Ronald James Paterson
as the Health and Disability Commissioner for a five-year term of office commencing on 5 March 2008 and expiring on 4 March 2013.
This reappointment was made by way of written notice to the Health and Disability Commissioner, pursuant to section 28(2) of the Crown Entities Act 2004.
Dated at Auckland this 17th day of December 2007.
HON. DAVID CUNLIFFE, Minister of Health.
go206
Medicines Act 1981
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product:
Xigris
Active Ingredient:
Drotrecogin alfa (activated) 20mg
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited
Manufacturer:
DSM Pharmaceuticals Inc, Greenville, North Carolina, United States of America
Product:
Xigris
Active Ingredient:
Drotrecogin alfa (activated) 5mg
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited
Manufacturer:
DSM Pharmaceuticals Inc, Greenville, North Carolina, United States of America
Dated this 14th day of January 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go288
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
5008 bibag for Haemodialysis Solution
Active Ingredient:
Sodium bicarbonate 100%w/w
Dosage Form:
Powder
New Zealand Sponsor:
Fresenius Medical Care Australia Pty Limited
Manufacturer:
Fresenius SMAD, Secteur Ouest, Savigny, LβArbresle Cede, France
Product:
Apo-Risperidone
Active Ingredient:
Risperidone 0.5mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Apotex Inc, Weston, Ontario, Canada
Product:
Apo-Risperidone
Active Ingredient:
Risperidone 1mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Apotex Inc, Weston, Ontario, Canada
Product:
Apo-Risperidone
Active Ingredient:
Risperidone 2mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Apotex Inc, Weston, Ontario, Canada
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2008, No 6
Gazette.govt.nz —
NZ Gazette 2008, No 6
β¨ LLM interpretation of page content
π₯ Reappointment of Health and Disability Commissioner
π₯ Health & Social Welfare17 December 2007
Reappointment, Health and Disability Commissioner, Crown Entities Act 2004
- Ronald James Paterson, Reappointed Health and Disability Commissioner
- HON. DAVID CUNLIFFE, Minister of Health
π₯ Consent to Distribution of Changed Medicine
π₯ Health & Social Welfare14 January 2008
Medicines, Distribution, Xigris, Drotrecogin alfa, Eli Lilly
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare14 January 2008
Medicines, Distribution, Haemodialysis, Risperidone, Fresenius, Apotex
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate